Phibro Animal Health (PAHC) Interest Expenses (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Interest Expenses came in at $10.7 million in Q1 2026, up 10.65% year-on-year from $9.7 million in Q1 2025, and down 14.42% quarter-over-quarter from $12.5 million in Q4 2025.
Phibro Animal Health (PAHC) Interest Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health's Interest Expenses history runs 14 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 10.65% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $44.7 million, a 30.83% increase from a year earlier, with the FY2025 full-year figure at $37.2 million, up 61.77% from the prior year.
- Interest Expenses declined to $10.7 million in Q1 2026 per PAHC's latest filing, from $12.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $12.5 million in Q3 2025 and bottomed at $1.9 million in Q2 2022.
- The 5-year median for Interest Expenses is $5.7 million (2023), against an average of $7.0 million.
- Across the five-year window, Interest Expenses sank 53.6% in 2022 and surged 189.73% in 2023, its largest moves.
- Year by year, Interest Expenses stood at $4.6 million in 2022, then grew by 23.66% to $5.7 million in 2023, then soared by 70.85% to $9.8 million in 2024, then gained by 27.64% to $12.5 million in 2025, then slipped by 14.42% to $10.7 million in 2026.
- Per Business Quant, the three latest PAHC Interest Expenses figures stand at $10.7 million (Q1 2026), $12.5 million (Q4 2025), and $12.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 10.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.68 Mn |
| Mar 31, 2026 | 10.68 Mn |
| Dec 31, 2025 | 12.48 Mn |
| Dec 31, 2025 | 12.48 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Dec 31, 2024 | 9.78 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Dec 31, 2023 | 5.72 Mn |